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Introduction
Colon cancer (CC) is the third most commonly diagnosed 
cancer across countries but the second in terms of mortality; 
its incidence is estimated of 1,096,601 number of new 
cases per year and 881,000 deaths are estimated to occur in 
2018 (1). Right-sided cancers (RSCs) are most commonly 
defined as cancers arising proximal to the splenic flexure 
while left-sided cancers (LSCs) are located distal to the 
splenic flexure (2-4). This cut point is often used because 
most of the transverse colon arises embryologically from 
the midgut, and only the distal third of it arises from 
the hindgut. Vascular supply has also been proposed as a 
defining characteristic of embryologic origin, the superior 
and inferior mesenteric arteries supplying the midgut 
and hindgut, respectively. Epidemiological studies have 
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demonstrated gender and age relationship with a higher 
incidence of RSC in women and elderly people (5,6). There 
are also differences in pathologic appearance (7-10), and in 
the molecular biological pattern (11,12). Therefore, it has 
been suggested to consider colorectal cancer as three distinct 
tumor entities: RSC, LSC and rectal cancer. There is 
differential prognosis by stage between patients with right- 
and left-sided CCs. In literature stage II RSC is reported 
with a slightly better prognosis as compared to LSC due to 
a higher prevalence of good-prognosis MSI-high tumors, 
while stage III RSC has a slightly worse prognosis (3,4,8). 
Moreover, analyses of prospective clinical trials of patients 
with stage III colorectal cancer who received adjuvant 
chemotherapy also demonstrated lower disease-free survival 
(DFS) in those with right-sided location (HR, 0.70; 95% CI, 
0.61–0.81) (13). Patients with metastatic RSC have worse 
prognosis as compared to those with LSC as well (14).
Before 90’s also rectal cancer had a poor prognosis 
because of high local recurrence rate. In 1988, Heald (15) 
introduced the concept of total mesorectal excision (TME) 
for rectal cancer which is based upon sharp dissection 
following embryological anatomical planes (16,17). TME 
provides a surgical specimen with an intact coverage, not 
only of the rectal tumor, but also of the main lymphatic 
drainage including the majority of regional lymph nodes, 
lymphatic vessels and surrounding fat tissue lying within 
mesorectum. Thereafter the development, standardization 
and widespread adoption of TME, surgery for rectal 
cancer has been reported with significant reduction of local 
recurrence rates and improvement of survival (15,18,19).
In 2009, Hohenberger (20) aimed at improving the 
outcome of patients with RSC by developing the same 
concept of TME also for RSC.
Therefore Hohenberger introduced the idea of complete 
mesocolic excision (CME) that is a new conception of 
right hemicolectomy for RSC based on three main issues: 
dissection of the embryological plane to remove a complete 
envelope containing the mesentery together with all the 
lymph nodes draining the tumor, a central vascular tie to 
remove the main lymph nodes in the central direction and 
resection of a sufficient length of bowel to remove the 
pericolic lymph nodes (20). The objectives of CME were to 
reduce local recurrence and to improve survival rates. The 
rationale behind this new concept of surgery for RSC was 
based on several points: the lymph node metastases of CC 
follow the supplying arteries; several studies have shown a 
survival benefit to higher lymph node yields after colonic 
resection (21); increasing negative lymph node count also 
correlates with survival in advanced colonic cancer (22,23) 
and finally, the ratio of lymph node metastases to the total 
number of harvested lymph nodes, known as the lymph 
node ratio (LNR), has been reported in several studies to be 
a better prognostic indicator than the number of involved 
lymph nodes, or pN status, alone (24).
In this last decade, many doubts and questions have been 
arised about safety and efficacy of CME together with its 
worldwide spread. Many authors have questioned whether a 
survival benefit from a greater lymph node yield truly exists 
considering that other factors are known to affect lymph 
node retrieval including patient age, immune status, tumor 
location, tumor characteristics and institutional factors 
(25,26).
Several studies have suggested that there isn’t any 
or only a minimal survival benefit in lymph node yield 
greater than 12 compared to that less than 12, particularly 
in the presence of good quality surgery and lymph node 
examination and that it is difficult to define a threshold 
number for lymph node retrieval (27,28).
Furthermore, several non-CME studies have failed to 
show a relationship between high vascular tie, and therefore 
greater lymph node yield and higher number of lymph node 
metastases, and/or improved survival (29,30). Others argue 
that metastases in lymph nodes outside conventional ranges 
of dissection represent distant metastases, and the extended 
resection will not influence the survival as they are related 
to a poor oncological outcome (31).
The aim of this systematic review was to investigate the 
safety, quality and outcomes of CME in patients with RSC.
We present the following article in accordance with the 
PRISMA reporting checklist (available at http://dx.doi.
org/10.21037/ales-20-41).
Material and methods
Literature search and systematic review were done adhering 
to the Cochrane Collaboration guidance (32) to reduce the 
risk of bias and error. The systematic review was conducted 
according to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement (33). 
Data collection, randomized controlled trials (RCTs) and 
non-randomized controlled studies (non-RCSs) concerning 
CME were searched for this review. No language 
restrictions were adopted during articles search. This study 
was registered with PROSPERO (187448).
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Search strategy
A systematic search of PubMed, Embase and the Cochrane 
Library was conducted on 12 December 2019.
The Cochrane database was searched using a combination 
of the following terms with the Boolean AND/OR 
operators: “Colonic Neoplasms”, “Colectomy”, “Colon”, 
“complete-mesocolic-excis”, “CME”, “central-vascular-
ligat”, “D3”, “lymphadenect”, “lymph-nod”, “Lymph Node 
Excision”, “right”, “ileocol”, “ileo-col”.
For the PubMed and Embase database searches, these 
same keywords (and variants) were used as text words 
and Medical Subject Headings (MeSH terms), and were 
combined by using Boolean operators as follows: (“Colonic 
Neoplasms” OR “Colectomy” OR “Colon” OR colon*[tiab] 
OR colectom*[tiab]) AND (complete-mesocolic-excis*[tiab] 
OR CME[tiab] OR central-vascular-ligat*[tiab] OR 
(D3[tiab] AND (lymphadenect*[tiab] OR lymph-nod*[tiab] 
OR “Lymph Node Excision”))) AND (right*[tiab] OR 
ileocol*[tiab] OR ileo-col*[tiab]).
Outcomes of interest
 Safety of CME, including intra-operative and 
postoperative surgical complications and postoperative 
mortality;
 Quality of CME, including total number of lymph 
nodes retrieved, total number of metastatic lymph 
nodes; mean ileo-colic and middle colic main trunk 
vessels lengths; total area and integrity rate (%) of 
resected mesocolon; details of mesocolic resection;
 Survival Outcomes, including overall survival (OS) and 
DFS at 3 and 5 years.
Inclusion and exclusion criteria
Inclusion criteria were as follows
Only English articles were selected at the end. The 
inclusion criteria were the following: 
 Studies including patients with pathologically 
verified CC;
 Studies with satisfactorily definition of CME 
technique, including a description of dissection in 
the embryologic mesocolic fascial planes and central 
vascular ligation (CVL) or D3 lymphadenectomy;
 Studies including at least one outcome of interest 
among their results.
Exclusion criteria were as follows
 Reviews and systematic reviews;
 Studies with abstract only, videos, oral communications, 
case reports and letters;
 Studies with less than 100 patients included;
 Studies from the same institution or overlapping 
patients (in these cases, we selected the study that 
included more patients or that was published later).
Studies selection
Our systematic review was conducted using Mendeley 
software. Five independent reviewers screened titles and 
abstracts identified by literature search. A total of 659 
potentially suitable articles were initially identified. The first 
step was to merge the duplicates, resulting in 516 remnant 
studies. In the second step these studies were checked for 
the pertinence by reading the titles and analyzing their 
abstracts. All studies excluded at this second step were 
documented along with the reasons for exclusion (Figure 1). 
Any discrepancies among reviewers were solved through 
consensus.
Full papers of selected abstracts were assessed to confirm 
whether also the full papers totally met inclusion criteria.
Data extraction was performed by five reviewers (FE, 
GO, LMR, LS, FS) and checked by a sixth reviewer (RR). 
Selected papers were identified by publication year and by 
the surname of the first author.
Results
Literature searches and inclusion assessment
Figure 1 summarizes the process of identification and 
selection of papers for inclusion in this systematic review, 
following the PRISMA guidelines (33).
Literature searches of electronic databases identified 
659 articles. After de-duplication, 516 titles/abstracts were 
screened by reviewers and 229 articles were excluded as 
having no pertinence to this systematic review. Titles/
abstracts of 287 potentially relevant papers were included 
for further evaluation. One hundred thirty-two studies have 
been excluded because they were reviews, abstracts, videos, 
oral communications, case reports and letters. Finally, 
105 papers were excluded because the number of included 
patients was less than 100. Of these, 29 further papers were 
left out after examining in detail the full paper; the reasons 
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for rejection are detailed in Figure 1.
Overall, we identified 21 studies about CME properly 
fulfilling inclusion and exclusion criteria (34-53).
Study characteristics
Of the 21 included studies, seven were from Korea, five 
from Europe, five from China, one was from Japan, one 
from Taiwan, one from North America and one from India. 
Most of the included papers were retrospective cohort 
studies and only two of them were prospective studies. The 
total number of included patients was 7,402 (Table 1).
Baseline patient characteristics
The weighted mean age of included patients was 65.42 
(range, 17–94) years; 51.27% (3,670 patients) of them were 
men (one study did not include patients’ gender data) (42). 
The CME was performed by open technique in 45% 
of cases and with a minimally invasive approach in the 
remnant 55% of cases (robotics, laparoscopy and hand-
assisted laparoscopy). The weighted mean operative time 
was 182.74 [35–664] minutes (min). The weighted mean 
length of stay was 9.86 [1–65] days. These baseline patient 
characteristics are reported in Table 1.
Pathologic outcomes
Pathologic data are summarized in Table 2. The weighted 
mean number of lymph nodes retrieved was 27.45 [1–88] 
and the mean number of metastatic nodes was 1.34 [0–48]. 
Only one study didn’t report the total number of lymph 
nodes yielded (50) while the number of metastatic nodes 













Studies included in the review
(n=21)
Records excluded after complete full text lecture
(n=134)
• Number of patients <100 105
• Articles in other languages 12
• Missing inclusion criteria 2
• Results not divided according with cancer site 15
Duplicates removed
(n=143)






• Videos and letters 11
• Only conference proceedings 48
• Abstracts 9
• Reviews 6
• Case Reports 58
Figure 1 PRISMA flow diagram of the study selection process. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-
Analyses.
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Subbiah (38) and Shin (43) were the only authors to report 
the rate of integrity of the mesocolic plane, which was 
high in both studies, 94% and 81% respectively. No one 
referred to Benz’s classification (55) to check the quality 
and completeness of dissection. Only Ouyang’s study (53) 
described the mean ileocolic vessel length, which was 12.6 
(range, 10–15) cm. Nobody analyzed the length of middle 
colic trunk. Most of the analyzed patients (41.6%) had a 
TNM Stage II disease while 17% of them had a stage I, 
39.7% a stage III and only the 1% of patients had a stage IV 
cancer.
Perioperative morbidity and mortality
Eighteen papers reported perioperative morbidity and 
mortality details (Table 3).
Spinoglio et al. (45) described a case of major vessels 
injury, while no one described intraoperative visceral 
injuries. Overall surgical complications rate was 5.5% 
and anastomotic leakage occurred in 1% of patients. The 
weighted mean operative blood loss was 65.14 [0–371] mL.
Overall operative mortality rate for included studies was 
0.5% and no one described intraoperative deaths.
Pelz (41) reported the higher reoperation rate (18.6%) 
among included studies, compared with a reintervention 
rate close to 1% of the others.
Survival outcomes
Ten studies detailed the adoption of adjuvant treatment. 
In total, 65% of patients in these studies underwent 
postoperative chemotherapy (34,37,44,46-51,54) (Table 4).
Five-year local recurrence and distant metastasis rates 
were 3% and 12.3% respectively.
Most of the included papers reported 5-year DFS and 
OS survival rates and their weighted means were 82.8% and 
84.3% respectively (35,37,43,45,47,49-51,54), whereas only 
four studies mentioned 3-year OS outcome (weighted mean 
89.6%) (34,43,52,53) and only three studies detailed 3-year 
DFS (weighted mean 82.4%) (34,52,53).
Discussion
Some Authors would like to introduce CME as the standard 
of care for RSC based on the supposed evidence of its 
better oncologic outcomes provided with same operative 
morbidity and mortality as compared to the classic right 
hemicolectomy (20,24,56,57). CME is claimed as the 
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adequate treatment for RSC because of the extensive 
lymph-node dissection which may include remote nodal 
basins and those along major first-order vessels such as the 
superior mesenteric artery.
Many studies showed that survival of CC is strictly 
related to the number of lymph nodes removed, despite 
the stage of the disease, patient demographics and tumor 
characteristics (21,58-60). Chen et al. reported that 
removing at least 15 lymph nodes increased median OS by 
11 months in patients with stage I, 54 months in stage II 
and 21 months in stage III cancer. He stated that surgeons 
must remove at least 15 nodes in every dissection for CCs 
and concluded “I would advise surgeons to remember that the 
number of nodes makes a difference” (21). Prandi et al. showed 
a direct relationship between the number of lymph node 
yielded and survival which is even strongly significant in 
stage B (pN0) patients (58). Swanson et al. demonstrated 
that the prognosis of T3N0 CC is dependent on the 
number of lymph nodes examined (59). Finally, Le Voyer 
et al. stated that the number of lymph nodes analyzed for 
staging CCs is, itself, a prognostic variable of outcome, 
even in lymph node negative disease (60). This significant 
improvement of survival is related to many reasons; one 
of these is stage migration, especially in earlier stages (I 
and II). In the present review the overall weighted-mean 
number of lymph nodes yielded was high (28,57). This 
result demonstrates that CME enables surgeons to remove 
more nodes even than those suggested by Chen (21), 
providing a better staging and increasing the survival of the 
disease.
The concept of surgical dissection along embryologic 
fascial planes allowing the excision of an intact mesocolon 
containing its regional lymph nodes is another key point 
of CME. The surgery along embryological fascial planes 
enables to reduce the hazard of cancer spillage inside the 
abdominal cavity. West et al. (57) showed better survival 
outcomes in patients with preserved integrity of mesocolic 
plane of dissection especially for stage III disease. In 
this review only Subbiah (38) and Shin (43) analyzed the 
integrity of mesocolic plane in their studies, and no one 
referred to Benz classification to objectively define the 
quality of dissection. As one of the main items of CME is 
the dissection following embryological planes, this lack 
represents a major limit of the studies included in the 
present review. Moreover, the absence of an objective 
procedure to check the quality of surgery makes impossible 
to assess the real extension of the operations performed in 
each study and how much the procedures described in the 
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Table 3 Perioperative morbidity and mortality of included studies
Reference, year
Intraoperative major 







Perioperative blood loss 
volume (mL), [range]





Pramateftakis (50), 2010 NR NR 1 (0.9) NR NR Wound dehiscence 8 (6.9); enterocutaneus fistula  
1 (0.9); abdominal bleeding 1 (0.9)
mesenteric vein Thrombosis 1 (0.9); deep venous thrombosis 1 (0.9); 
cerebral vascular accident 1 (0.9); atrial fibrillation 1 (0.9)
0 NR
Kang (40), 2014 NR NR NR NR NR Wound infection 1 (0.7) Ileus 1 (0.7); urinary retention 4 (3.1) 0 NR
Bae (37), 2014 NR NR 1 (0.58) NR 41.95 [0–304] Wound infection 7 (4.1); abdominal bleeding 1 (0.6); 
abdominal abscess 1 (0.6); chylous leakage 15 (8.8)
Ileus 5 (2.9); pulmonary complication 1 (0.6); urinary tract infection 1 (0.6) NR 1 (0.58)
Liang (42), 2015 NR NR 4 (1.6) NR 104.5 [58–150] Wound infection 10 (4.0) Urinary tract infection 8 (3.0); pneumonia 2 (0.8); ileus 4 (1.6); duodenal 
paralysis 7 (2.9); myocardial infarction 1 (0.4); cerebrovascular accident  
1 (0.4); pulmonary embolism 1 (0.4); deep vein thrombosis 1 (0.4)
NR NR
Cho (54), 2015 NR NR 5 (0.6) NR NR Wound infection 9 (1.2); abdominal bleeding 1 (0.1); 
bowel necrosis 1 (0.1)
Pulmonary disease 6 (0.8); ileus 9 (1.2); cerebrovascular infarction 1 (0.1); 
ARDS 1 (0.1)
0 2 (0.2)
Subbiah (38), 2016 NR NR 1 (0.5) NR NR Wound infection 4 (2.0); abdominal abscess 1 (0.5) Ileus 11 (5.0); urinary complication 2 (1.0); respiratory complication 7 (3.0); 
cardiac complication 1(0.5)
NR NR
Huang (39), 2015 NR NR NR NR 105.53 [0–350] Wound infection 4 (4.0); anastomotic bleeding 1 (1.0) Pneumonia 3 (3.0) NR NR
Takahashi (36), 2017 NR NR 1 (0.5) NR 43 [20– 100] Wound infection 10 (5.0); abdominal bleeding 1 (0.5); 
abdominal abscess 1 (0.5)
Ileus 4 (2.0); Thrombosis 1 (0.5); urinary complication 1 (0.5); 
cardiovascular complication 1 (0.5); pneumonia 1 (0.5)
NR 0
Siani (51), 2017 NR NR 15 (2.5) NR 53 [0–123] Wound infection 63 (10.6) Pneumonia 59 (5.8); pleural effusion 38 (4.7); urinary tract infection  
36 (6.0); ileus 9 (1.5); deep venous thrombosis 3 (0.5)
NR NR
Kim (34), 2016 NR NR 2 (0.9) NR 75 [0–371] Wound infection 25 (11.6); abdominal bleeding 3 (1.4); 
abdominal abscess 4 (1.9); chylous leakage 8 (3.7)
Respiratory complication 11 (5.1); urinary complication 3 (1.4); ileus  
13 (6.0)
NR 4 (2)
Sheng (48), 2017 NR NR 0 NR 0 Wound infection 6 (4.0); chylous leakage 2 (1.3) Ileus 4 (3.0); respiratory complication 1 (0.6); gastroplegia 3 (2.0) NR NR
Kim (49), 2017 NR NR NR NR NR NR NR NR NR
Shin (43), 2018 NR NR 18 (0.8) NR NR Wound infection 61 (3.0) Ileus 81 (4.0) NR 1 (0.04)
Wang (52), 2017 0 0 1 (0.6) 2 (1.1) 74.2 [18–130] Wound infection 3 (1.74); chylous leakage 22 (12.8); 
anastomotic bleeding 1 (0.58)
Pneumonia 1 (0.6) 0 0 
Bertelsen (46), 2019 NR NR NR NR NR NR NR NR 13 (5)
Li (35), 2018 NR NR 3 (2.8) NR 97 [50–300] Wound infection 3 (2.8); chylous leakage 4 (3.7); 
abdominal abscess 3 (2.8)
Ileus 1 (0.9); gastroplegia 2 (1.8) 0 0
Spinoglio (45), 2019 1 (0.5) NR 2 (1.0) 4 (2.0) NR Wound infection 15 (7.4); abdominal bleeding 8 (4.0) Ileus 21 (10.4); pneumonia 4 (2.0); acute respiratory failure 3 (1.5); 
arrhythmia 3 (1.5); acute myocardial Infarction 1 (0.5); stroke 1 (0.5); 
urinary complication 4 (2.0)
NR 1 (0.5) 
Pelz (41), 2018 NR NR NR 52 (18.6) NR NR NR NR 4 (1.4) 
Lee (47), 2019 NR NR NR NR NR NR NR NR 1 (0.1)
Sammour (44), 2020 0 0 2 (1.4) 1 (0.7) 50 median  NR NR 0 0
Ouyang (53), 2019 NR NR 1 (0.9) 1 (0.9) 108.4 [61–156] Wound infection 3 (2.8); fat liquefaction wound 2 (1.9) Ileus 5 (4.7); pulmonary infection 1 (0.9); urinary tract infection 1 (0.9) 0 0 
Overall 1 (0.2) 0 57 (1.0) 60 (7.0) 65.14 [0–371]* 314 (5.5) 399 (6.9) 0 27 (0.5)
*, All results are calculated as weighted arithmetic mean, all median values are excluded. NR, not recorded.
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48 (41.7) NR NR NR NR 72.4 NR
Kang (40), 2014 NR NR 7 (5.5) NR NR NR NR
Bae (37), 2014 133 (78.2) 7 (4.1) 20 (11.8) NR NR 84 78
Liang (42), 2015 NR NR NR NR NR NR 66.8
Cho (54), 2015 615 (79.6) 34 (4.4) 114 (14.7) NR NR 84 82.8
Subbiah (38), 2016 NR NR NR NR NR NR NR
Huang (39), 2015 NR NR NR NR NR NR NR
Takahashi (36), 2017 NR NR NR NR NR NR NR
Siani (51), 2017 425 (70.8) NR NR NR NR 83.0 78.3
Kim (34), 2016 144 (71.3) NR NR 87.4 78.6 NR NR
Sheng (48), 2017 127 (84.7) NR NR NR NR NR NR
Kim (49), 2017 99 (79.2) 6 (4.2) NR NR NR 82.6 83.5
Shin (43), 2018 NR 47 (2.0) 270 (12.0) 89.7 NR NR 86
Wang (52), 2017 NR 3 (1.7) 14 (8.1) 89.1 81.7 NR NR
Bertelsen (46), 2019 78 (30.4) 25 (10.0) NR NR NR NR NR
Li (35), 2018  NR 3 (3.0) 16 (14.8) NR NR 73.0 57.4
Spinoglio (45), 2019 NR NR NR NR NR 75.0 84.2
Pelz (41), 2018 NR NR NR NR NR NR NR
Lee (47), 2019 491 (58.8) NR NR NR NR 91.1 85.6
Sammour (44), 2020 56 (39.7) 0 26 (18.4) NR NR NR NR
Ouyang (53), 2019 NR 3 (2.8) 6 (5.6) 93.5 91.6 NR NR
Overall 2,216 (65.0) 128 (3.0) 473 (12.3) 89.6 82.4 84.3 82.8
OS, overall survival; DFS, disease-free survival; NR, not recorded.
different studies are homogeneous.
Recently Perrakis (61), claimed that CME can be 
implemented in surgical departments after previous 
adequate teaching without increasing postoperative 
complications and mortality. Despite a negative report 
by Pelz et al. (41), describing a high reoperation rate 
(18.6%), the overall postoperative outcomes of the present 
review showed acceptable findings: reoperation rate was 
7%, surgical complications were 5.5%, intraoperative 
mortality was 0% and 30-day postoperative mortality was 
0.5%. These results are consistent with those observed 
after standard nonCME right hemicolectomy (62,63). 
Anastomotic leak occurred in 1% of cases; showing the 
same incidence observed after standard right colectomy 
(64,65). Nevertheless, this is a really demanding procedure, 
requiring proved skill in advanced minimally invasive 
procedures.
Recently, a large retrospective study investigated 
postoperative and oncological outcomes of 3,518 patients 
submitted to right colectomy for RSC with different 
approaches (open, laparoscopic and robotic). The operative 
times were significantly different among the subgroups: 
135.9±89.2 min for open surgery, 142.5±63.3 min for 
laparoscopy and 187.2±81.4 min for robotic procedures 
while the length of stay was significantly shorter after 
minimally-invasive approach (5.2±4.7 and 4.4±2.4 days after 
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laparoscopic and robotic surgery respectively) compared 
to open surgery (7.9±7.7 days) (62). In the present review 
the resections were mostly performed with minimally 
invasive approach (55%); the weighted mean operative time 
and length of stay (LOS) were 182.74 min and 9.86 days 
respectively.
In a study of over 83,000 CC survivors based on the 
Surveillance Epidemiology End Results (SEER) database, 
the 5-year cause-specific survival was ≥80% for all stages 
together except from stage IV (48%) (66). In 2018, Qiu (67) 
detailed cancer-specific survival differences between RSCs 
and LSCs using SEER database, documenting a 5-year 
cause-specific survival of 68.1% after standard colectomy 
for RCS (92,8% in stage I, 85.5% in stage II, 64.9% in stage 
III and 11.2% in stage IV disease). Narayanan et al. recently 
published a large retrospective study of the National Cancer 
Database investigating the data from 379785 patients to 
assess the OS. The Authors found a 3- and 5-year OS of 
61% and 51% (68). A recent analysis of 3,622 patients with 
CC derived from two French digestive cancer registries 
reported that 1.6% of patients with RSC developed a local 
recurrence 5 to 10 years after resection (69).
In the present study 3- and 5-year OS was 89.6% and 
82.8%; Therefore, it was higher compared with survival 
results of standard right colectomies reported in recent 
literature.
This study has several limitations. First, all of the 
included studies were case series of a prospective or 
retrospective nature and there was no Level 1 evidence 
from a RCT. Second, these studies are not homogeneous 
as concerns the outcomes of interest of this review detailed 
in materials and methods section; most of them have 
important missing outcomes; none of them has investigated 
all of these items and furthermore, the majority of these 
studies considered only few outcomes of those requested. 
The last point is that the majority of included patients had 
early-stage diseases (58.6% stage I–II). This limitation 
represents a confounding factor for the final analysis of 
survival outcomes.
In conclusion, despite these limitations, data from 
extensive literature search document that CME with CVL 
for RCS is a promising procedure which can provide better 
oncological and survival outcomes without increasing 
postoperative morbidity and mortality as compared to 
standard right colectomy. However, to date, the quality of 
evidence is limited and does not consistently support the 
superiority of CME. More reliable data from large sample 
size RCTs are needed before CME can be recommended as 
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